High throughput sequencing from Roche

By External Press Release Author
Monday, 11 June, 2007


Roche Diagnostics has launched the second generation of its high throughput sequencing technology, the Genome Sequencer FLX System.

Expanding upon the proven GS 20 System, over 100 million bases can be generated per 7.5-hour instrument run, with reads averaging 200 to 300 bases - ideal for a wide range of applications including amplicon resequencing, transcriptome analysis, gene regulation studies, and comparative genome sequencing.

Australia's largest genomics services company, the Australian Genome Research Facility, has the first Roche Genome Sequencer FLX system in Australia.

AGRF's acquisition of the Genome Sequencer FLX will complement current Sanger-based sequencing and bioinformatics services to deliver cutting edge sequencing technology to the Australian genomics research and industry sectors.

Please contact Tony Feneziani on 0448 864 095 for details of the services that AGRF offers.

Roche Diagnostics Australia

Related Articles

Shingles vaccine may lower risk of dementia, heart disease

It turns out that the shingles vaccine may have public-health benefits beyond its intended...

How does the brain evaluate rewards?

Neuroscientists have shown how nerve cells in the amygdala not only encode the probability and...

Breakthrough drug prevents long COVID symptoms in mice

Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd